Ingenol-3-acylates III and ingenol-3-carbamates

wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vedsø Per, Vifian Thomas, Högberg Thomas, Grue-Sørensen Gunnar, Månsson Kristoffer, Liang Xifu
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Vedsø Per
Vifian Thomas
Högberg Thomas
Grue-Sørensen Gunnar
Månsson Kristoffer
Liang Xifu
description wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceutically active compounds-in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9708286B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9708286B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9708286B23</originalsourceid><addsrcrecordid>eNrjZND3zEtPzcvP0TXWTUyuzEksSS1W8PT0VEjMS1HIhEslJxYlJeaCJHkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosKW5gYWRhZmTkTERSgBdsSmh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Ingenol-3-acylates III and ingenol-3-carbamates</title><source>esp@cenet</source><creator>Vedsø Per ; Vifian Thomas ; Högberg Thomas ; Grue-Sørensen Gunnar ; Månsson Kristoffer ; Liang Xifu</creator><creatorcontrib>Vedsø Per ; Vifian Thomas ; Högberg Thomas ; Grue-Sørensen Gunnar ; Månsson Kristoffer ; Liang Xifu</creatorcontrib><description>wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceutically active compounds-in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170718&amp;DB=EPODOC&amp;CC=US&amp;NR=9708286B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170718&amp;DB=EPODOC&amp;CC=US&amp;NR=9708286B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Vedsø Per</creatorcontrib><creatorcontrib>Vifian Thomas</creatorcontrib><creatorcontrib>Högberg Thomas</creatorcontrib><creatorcontrib>Grue-Sørensen Gunnar</creatorcontrib><creatorcontrib>Månsson Kristoffer</creatorcontrib><creatorcontrib>Liang Xifu</creatorcontrib><title>Ingenol-3-acylates III and ingenol-3-carbamates</title><description>wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceutically active compounds-in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND3zEtPzcvP0TXWTUyuzEksSS1W8PT0VEjMS1HIhEslJxYlJeaCJHkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosKW5gYWRhZmTkTERSgBdsSmh</recordid><startdate>20170718</startdate><enddate>20170718</enddate><creator>Vedsø Per</creator><creator>Vifian Thomas</creator><creator>Högberg Thomas</creator><creator>Grue-Sørensen Gunnar</creator><creator>Månsson Kristoffer</creator><creator>Liang Xifu</creator><scope>EVB</scope></search><sort><creationdate>20170718</creationdate><title>Ingenol-3-acylates III and ingenol-3-carbamates</title><author>Vedsø Per ; Vifian Thomas ; Högberg Thomas ; Grue-Sørensen Gunnar ; Månsson Kristoffer ; Liang Xifu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9708286B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Vedsø Per</creatorcontrib><creatorcontrib>Vifian Thomas</creatorcontrib><creatorcontrib>Högberg Thomas</creatorcontrib><creatorcontrib>Grue-Sørensen Gunnar</creatorcontrib><creatorcontrib>Månsson Kristoffer</creatorcontrib><creatorcontrib>Liang Xifu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Vedsø Per</au><au>Vifian Thomas</au><au>Högberg Thomas</au><au>Grue-Sørensen Gunnar</au><au>Månsson Kristoffer</au><au>Liang Xifu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Ingenol-3-acylates III and ingenol-3-carbamates</title><date>2017-07-18</date><risdate>2017</risdate><abstract>wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceutically active compounds-in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9708286B2
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Ingenol-3-acylates III and ingenol-3-carbamates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A51%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Veds%C3%B8%20Per&rft.date=2017-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9708286B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true